

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.30999651 |
| 2 | interkinetic nuclear migration (GO:0022027) | 4.75906935 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.72639629 |
| 4 | protein K11-linked deubiquitination (GO:0035871) | 4.24656900 |
| 5 | cellular response to ethanol (GO:0071361) | 4.16231566 |
| 6 | protein K48-linked deubiquitination (GO:0071108) | 4.14162963 |
| 7 | regulation of pigment cell differentiation (GO:0050932) | 4.11428158 |
| 8 | neural tube formation (GO:0001841) | 4.10197331 |
| 9 | histone H3-K4 trimethylation (GO:0080182) | 4.02439529 |
| 10 | positive regulation of developmental pigmentation (GO:0048087) | 3.95462659 |
| 11 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.78098488 |
| 12 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.72571860 |
| 13 | regulation of establishment of cell polarity (GO:2000114) | 3.66747389 |
| 14 | macroautophagy (GO:0016236) | 3.63048086 |
| 15 | mitotic sister chromatid cohesion (GO:0007064) | 3.60809651 |
| 16 | phospholipid homeostasis (GO:0055091) | 3.59957472 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54634891 |
| 18 | negative regulation of cell killing (GO:0031342) | 3.54634891 |
| 19 | histone mRNA catabolic process (GO:0071044) | 3.54137683 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.51324908 |
| 21 | protein targeting to vacuole (GO:0006623) | 3.49289508 |
| 22 | protein targeting to lysosome (GO:0006622) | 3.49289508 |
| 23 | establishment of protein localization to vacuole (GO:0072666) | 3.49289508 |
| 24 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.45280161 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45097713 |
| 26 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.41809848 |
| 27 | histone H3-K9 methylation (GO:0051567) | 3.40913379 |
| 28 | histone H3-K4 methylation (GO:0051568) | 3.36970939 |
| 29 | nucleus localization (GO:0051647) | 3.35415941 |
| 30 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.33935729 |
| 31 | establishment of protein localization to Golgi (GO:0072600) | 3.30997704 |
| 32 | positive regulation of histone deacetylation (GO:0031065) | 3.30781704 |
| 33 | histone H3-K36 demethylation (GO:0070544) | 3.24444381 |
| 34 | protein K63-linked deubiquitination (GO:0070536) | 3.23600819 |
| 35 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.22203742 |
| 36 | mannose metabolic process (GO:0006013) | 3.17347767 |
| 37 | peptidyl-lysine trimethylation (GO:0018023) | 3.15080091 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.14324011 |
| 39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.14324011 |
| 40 | protein localization to Golgi apparatus (GO:0034067) | 3.12784496 |
| 41 | nuclear pore complex assembly (GO:0051292) | 3.09309813 |
| 42 | histone H3-K9 modification (GO:0061647) | 3.06946709 |
| 43 | protein targeting to Golgi (GO:0000042) | 3.06706085 |
| 44 | positive regulation of granulocyte differentiation (GO:0030854) | 3.02566822 |
| 45 | rRNA catabolic process (GO:0016075) | 2.96066430 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 2.95967690 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.95436476 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94905270 |
| 49 | snRNA transcription (GO:0009301) | 2.91991679 |
| 50 | hepatocyte apoptotic process (GO:0097284) | 2.90006985 |
| 51 | regulation of protein polyubiquitination (GO:1902914) | 2.89470155 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.88821876 |
| 53 | positive thymic T cell selection (GO:0045059) | 2.87553331 |
| 54 | regulation of ARF protein signal transduction (GO:0032012) | 2.86099778 |
| 55 | microtubule anchoring (GO:0034453) | 2.83623988 |
| 56 | regulation of DNA endoreduplication (GO:0032875) | 2.83020506 |
| 57 | negative regulation of granulocyte differentiation (GO:0030853) | 2.82854604 |
| 58 | embryonic hemopoiesis (GO:0035162) | 2.81948054 |
| 59 | lipoprotein transport (GO:0042953) | 2.81550202 |
| 60 | early endosome to late endosome transport (GO:0045022) | 2.79058778 |
| 61 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.77508173 |
| 62 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.77508173 |
| 63 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.77508173 |
| 64 | pericardium development (GO:0060039) | 2.76361128 |
| 65 | negative regulation of neurotransmitter transport (GO:0051589) | 2.75276410 |
| 66 | growth hormone receptor signaling pathway (GO:0060396) | 2.74141799 |
| 67 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.72646538 |
| 68 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.71651396 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71380717 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 2.71380717 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71380717 |
| 72 | modulation by symbiont of host defense response (GO:0052031) | 2.71380717 |
| 73 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71380717 |
| 74 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71380717 |
| 75 | lipid translocation (GO:0034204) | 2.70391227 |
| 76 | phospholipid translocation (GO:0045332) | 2.70391227 |
| 77 | B cell receptor signaling pathway (GO:0050853) | 2.69118734 |
| 78 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.69003696 |
| 79 | histone lysine methylation (GO:0034968) | 2.68822397 |
| 80 | regulation of mRNA catabolic process (GO:0061013) | 2.68595525 |
| 81 | histone H3-K9 demethylation (GO:0033169) | 2.67917017 |
| 82 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.67718556 |
| 83 | I-kappaB phosphorylation (GO:0007252) | 2.66837732 |
| 84 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.66616212 |
| 85 | iron ion import (GO:0097286) | 2.64253072 |
| 86 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.63413297 |
| 87 | NLS-bearing protein import into nucleus (GO:0006607) | 2.61847177 |
| 88 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.59537788 |
| 89 | regulation of hippo signaling (GO:0035330) | 2.57189790 |
| 90 | striated muscle atrophy (GO:0014891) | 2.57008912 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.55592134 |
| 92 | positive T cell selection (GO:0043368) | 2.55564002 |
| 93 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.55313085 |
| 94 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.55313085 |
| 95 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.53846183 |
| 96 | activated T cell proliferation (GO:0050798) | 2.52485293 |
| 97 | prenylation (GO:0097354) | 2.52242137 |
| 98 | protein prenylation (GO:0018342) | 2.52242137 |
| 99 | dosage compensation (GO:0007549) | 2.50705351 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.50437373 |
| 101 | Golgi to endosome transport (GO:0006895) | 2.49115980 |
| 102 | replicative senescence (GO:0090399) | 2.48731335 |
| 103 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.48190512 |
| 104 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.46734676 |
| 105 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.46734676 |
| 106 | peptidyl-lysine methylation (GO:0018022) | 2.46453794 |
| 107 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.43851644 |
| 108 | negative thymic T cell selection (GO:0045060) | 2.43127657 |
| 109 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.42636577 |
| 110 | negative T cell selection (GO:0043383) | 2.40374681 |
| 111 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.40127132 |
| 112 | pore complex assembly (GO:0046931) | 2.39993438 |
| 113 | cilium movement (GO:0003341) | 2.39753460 |
| 114 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.39526465 |
| 115 | regulation of B cell differentiation (GO:0045577) | 2.38378385 |
| 116 | B cell homeostasis (GO:0001782) | 2.38266836 |
| 117 | stress granule assembly (GO:0034063) | 2.36523949 |
| 118 | phospholipid dephosphorylation (GO:0046839) | 2.35766553 |
| 119 | import into cell (GO:0098657) | 2.35744238 |
| 120 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.35112291 |
| 121 | macrophage activation involved in immune response (GO:0002281) | 2.34889206 |
| 122 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.34649171 |
| 123 | histone lysine demethylation (GO:0070076) | 2.34147163 |
| 124 | photoreceptor cell maintenance (GO:0045494) | 2.34133760 |
| 125 | neutrophil mediated immunity (GO:0002446) | 2.32776307 |
| 126 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.32742796 |
| 127 | response to host immune response (GO:0052572) | 2.32742796 |
| 128 | regulation of RNA export from nucleus (GO:0046831) | 2.32624367 |
| 129 | response to host (GO:0075136) | 2.31831134 |
| 130 | response to host defenses (GO:0052200) | 2.31831134 |
| 131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.31831134 |
| 132 | positive regulation of mRNA catabolic process (GO:0061014) | 2.30640897 |
| 133 | nuclear pore organization (GO:0006999) | 2.29691724 |
| 134 | central nervous system neuron axonogenesis (GO:0021955) | 2.29213562 |
| 135 | cellular response to growth hormone stimulus (GO:0071378) | 2.28961672 |
| 136 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.28253302 |
| 137 | urea cycle (GO:0000050) | 2.28140401 |
| 138 | urea metabolic process (GO:0019627) | 2.28140401 |
| 139 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.27976627 |
| 140 | lipid phosphorylation (GO:0046834) | 2.27726390 |
| 141 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.27548141 |
| 142 | phosphatidylinositol phosphorylation (GO:0046854) | 2.27506577 |
| 143 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.27043849 |
| 144 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.27037964 |
| 145 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.26755270 |
| 146 | natural killer cell mediated immunity (GO:0002228) | 2.26222485 |
| 147 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.26222485 |
| 148 | regulation of histone H3-K9 methylation (GO:0051570) | 2.25930052 |
| 149 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.25466472 |
| 150 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.25340224 |
| 151 | skeletal muscle adaptation (GO:0043501) | 2.24228523 |
| 152 | establishment of nucleus localization (GO:0040023) | 2.20047822 |
| 153 | axoneme assembly (GO:0035082) | 2.19360460 |
| 154 | olfactory bulb development (GO:0021772) | 2.19221860 |
| 155 | regulation of protein glycosylation (GO:0060049) | 2.18673276 |
| 156 | regulation of Rab GTPase activity (GO:0032313) | 2.15479865 |
| 157 | positive regulation of Rab GTPase activity (GO:0032851) | 2.15479865 |
| 158 | muscle atrophy (GO:0014889) | 2.15065399 |
| 159 | cilium morphogenesis (GO:0060271) | 2.15049276 |
| 160 | cilium organization (GO:0044782) | 2.15025107 |
| 161 | epithelial cilium movement (GO:0003351) | 2.14843136 |
| 162 | negative regulation of sodium ion transport (GO:0010766) | 2.13935227 |
| 163 | microtubule nucleation (GO:0007020) | 2.13462491 |
| 164 | definitive hemopoiesis (GO:0060216) | 2.12717718 |
| 165 | cilium assembly (GO:0042384) | 2.12397129 |
| 166 | fucose catabolic process (GO:0019317) | 2.11475709 |
| 167 | L-fucose metabolic process (GO:0042354) | 2.11475709 |
| 168 | L-fucose catabolic process (GO:0042355) | 2.11475709 |
| 169 | oocyte development (GO:0048599) | 2.09207387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.86857263 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.46240360 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.42836598 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.34091966 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.26439122 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.74510474 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51194560 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39404287 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.24485989 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.22730850 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.18580980 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13530491 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08717436 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.07666535 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06487501 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04744087 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04588551 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04216585 |
| 19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02026388 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00744426 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.94633330 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94266626 |
| 23 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92570195 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91754217 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85804234 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.84484150 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83993125 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.83293662 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82953208 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.78592766 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73960967 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72061212 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69788767 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69390161 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68832936 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68229806 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68079504 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67521825 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63280701 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62139256 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61599938 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59907718 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.59636785 |
| 44 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58570737 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57231449 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56539272 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56074392 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51483127 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51104369 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51104369 |
| 51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50216685 |
| 52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49912304 |
| 53 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.49261472 |
| 54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.46262886 |
| 55 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.44961373 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43386934 |
| 57 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43140566 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42756399 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.40633192 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39881016 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39402275 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38673698 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38415962 |
| 64 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38219234 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38076526 |
| 66 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36616874 |
| 67 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.36342486 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35879882 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35637425 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35135778 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35135778 |
| 72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33265296 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33049412 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32046951 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.31539226 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30567852 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29911995 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29736703 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29535926 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29353103 |
| 81 | MYB_26560356_Chip-Seq_TH1_Human | 1.28516497 |
| 82 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26965671 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26707289 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25753217 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24826812 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24621551 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23934295 |
| 88 | MYC_22102868_ChIP-Seq_BL_Human | 1.23638341 |
| 89 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22759522 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22593921 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22593921 |
| 92 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21471725 |
| 93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21304204 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21227547 |
| 95 | MYB_26560356_Chip-Seq_TH2_Human | 1.21211956 |
| 96 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20620108 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20460932 |
| 98 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.19878146 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19804229 |
| 100 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.19492686 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19228332 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16852161 |
| 103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16552562 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15912004 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14828412 |
| 106 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14762046 |
| 107 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14030587 |
| 108 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13909410 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13907452 |
| 110 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13766304 |
| 111 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.13471577 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13284224 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12471013 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11619655 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.11538974 |
| 116 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10654288 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10427503 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10299385 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09831903 |
| 120 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.08787048 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08317312 |
| 122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08273033 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08167784 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07694777 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07688580 |
| 126 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.07122475 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06879265 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05962269 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05822811 |
| 130 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04393960 |
| 131 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04264645 |
| 132 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04061752 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03712362 |
| 134 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03579446 |
| 135 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03228153 |
| 136 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.02605417 |
| 137 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02331713 |
| 138 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02227369 |
| 139 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01164679 |
| 140 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00810783 |
| 141 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00351961 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00341721 |
| 143 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99895723 |
| 144 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96950595 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 0.94715464 |
| 146 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93973614 |
| 147 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.92669292 |
| 148 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.92504826 |
| 149 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91233517 |
| 150 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90428974 |
| 151 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89949452 |
| 152 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88796292 |
| 153 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87403364 |
| 154 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85334158 |
| 155 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85156535 |
| 156 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85007765 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84031209 |
| 158 | UTX_26944678_Chip-Seq_JUKART_Human | 0.83769548 |
| 159 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83628790 |
| 160 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83598076 |
| 161 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82782068 |
| 162 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81994259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.96182476 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.36508238 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.05164000 |
| 4 | MP0003183_abnormal_peptide_metabolism | 2.59496920 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.55537115 |
| 6 | MP0000383_abnormal_hair_follicle | 2.43031132 |
| 7 | MP0003045_fibrosis | 2.31256687 |
| 8 | MP0003252_abnormal_bile_duct | 2.16347010 |
| 9 | MP0003646_muscle_fatigue | 2.13075948 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.12129045 |
| 11 | MP0005365_abnormal_bile_salt | 2.11666688 |
| 12 | MP0002006_tumorigenesis | 2.10394666 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.06134156 |
| 14 | MP0010307_abnormal_tumor_latency | 2.04058306 |
| 15 | MP0002396_abnormal_hematopoietic_system | 1.98103899 |
| 16 | MP0000371_diluted_coat_color | 1.96771203 |
| 17 | MP0005076_abnormal_cell_differentiation | 1.92102645 |
| 18 | MP0005670_abnormal_white_adipose | 1.86908525 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 1.84010878 |
| 20 | MP0010678_abnormal_skin_adnexa | 1.83739338 |
| 21 | MP0001800_abnormal_humoral_immune | 1.81022889 |
| 22 | MP0005360_urolithiasis | 1.79214395 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.75835947 |
| 24 | MP0004808_abnormal_hematopoietic_stem | 1.74139777 |
| 25 | MP0000685_abnormal_immune_system | 1.71774353 |
| 26 | MP0002009_preneoplasia | 1.71515036 |
| 27 | MP0003868_abnormal_feces_composition | 1.65606208 |
| 28 | MP0003787_abnormal_imprinting | 1.64468929 |
| 29 | MP0003195_calcinosis | 1.61601467 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.58738386 |
| 31 | MP0004381_abnormal_hair_follicle | 1.58458048 |
| 32 | MP0003303_peritoneal_inflammation | 1.56650123 |
| 33 | MP0001790_abnormal_immune_system | 1.56366503 |
| 34 | MP0005387_immune_system_phenotype | 1.56366503 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.56252481 |
| 36 | MP0002928_abnormal_bile_duct | 1.55239246 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.52467638 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.52133082 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.47306959 |
| 40 | MP0003890_abnormal_embryonic-extraembry | 1.46535258 |
| 41 | MP0006054_spinal_hemorrhage | 1.44240770 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.43153983 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.42543812 |
| 44 | MP0004043_abnormal_pH_regulation | 1.41258653 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.40753894 |
| 46 | MP0002419_abnormal_innate_immunity | 1.39213709 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.37058016 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.36125566 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.33669688 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.32568804 |
| 51 | MP0001873_stomach_inflammation | 1.32130602 |
| 52 | MP0002723_abnormal_immune_serum | 1.31845623 |
| 53 | MP0004947_skin_inflammation | 1.31497467 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.30776414 |
| 55 | MP0003436_decreased_susceptibility_to | 1.26199232 |
| 56 | MP0009278_abnormal_bone_marrow | 1.26019823 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.25296579 |
| 58 | MP0002398_abnormal_bone_marrow | 1.24963337 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.24741608 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.24741608 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.24241302 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.24237539 |
| 63 | MP0001819_abnormal_immune_cell | 1.23963133 |
| 64 | MP0004484_altered_response_of | 1.20792485 |
| 65 | MP0002168_other_aberrant_phenotype | 1.20710931 |
| 66 | MP0001666_abnormal_nutrient_absorption | 1.19580961 |
| 67 | MP0005671_abnormal_response_to | 1.15720049 |
| 68 | MP0004084_abnormal_cardiac_muscle | 1.14390269 |
| 69 | MP0008877_abnormal_DNA_methylation | 1.14303096 |
| 70 | MP0000609_abnormal_liver_physiology | 1.13856369 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.13744028 |
| 72 | MP0008057_abnormal_DNA_replication | 1.12573445 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 1.11054349 |
| 74 | MP0003724_increased_susceptibility_to | 1.10218151 |
| 75 | MP0009697_abnormal_copulation | 1.09652556 |
| 76 | MP0001324_abnormal_eye_pigmentation | 1.09380128 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.09322748 |
| 78 | MP0000716_abnormal_immune_system | 1.08168869 |
| 79 | MP0003121_genomic_imprinting | 1.08027430 |
| 80 | MP0002909_abnormal_adrenal_gland | 1.07903209 |
| 81 | MP0004142_abnormal_muscle_tone | 1.05681864 |
| 82 | MP0001661_extended_life_span | 1.05086994 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.04757236 |
| 84 | MP0001984_abnormal_olfaction | 1.03985786 |
| 85 | MP0003632_abnormal_nervous_system | 1.01191578 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 1.00672762 |
| 87 | MP0000427_abnormal_hair_cycle | 0.99526853 |
| 88 | MP0004883_abnormal_blood_vessel | 0.98835608 |
| 89 | MP0005025_abnormal_response_to | 0.97753580 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.97578754 |
| 91 | MP0003091_abnormal_cell_migration | 0.96906675 |
| 92 | MP0002722_abnormal_immune_system | 0.95940288 |
| 93 | MP0004134_abnormal_chest_morphology | 0.95875206 |
| 94 | MP0002102_abnormal_ear_morphology | 0.94374066 |
| 95 | MP0010155_abnormal_intestine_physiology | 0.93905290 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.93087743 |
| 97 | MP0005646_abnormal_pituitary_gland | 0.92831868 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.92777857 |
| 99 | MP0002075_abnormal_coat/hair_pigmentati | 0.91577398 |
| 100 | MP0009046_muscle_twitch | 0.91527677 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.91288718 |
| 102 | MP0004924_abnormal_behavior | 0.91288718 |
| 103 | MP0002254_reproductive_system_inflammat | 0.91266286 |
| 104 | MP0009115_abnormal_fat_cell | 0.89258387 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.88572680 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.88476505 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.87545596 |
| 108 | MP0003866_abnormal_defecation | 0.86099914 |
| 109 | MP0008995_early_reproductive_senescence | 0.85746306 |
| 110 | MP0005253_abnormal_eye_physiology | 0.85654097 |
| 111 | MP0005408_hypopigmentation | 0.85422501 |
| 112 | MP0004130_abnormal_muscle_cell | 0.85356970 |
| 113 | MP0002837_dystrophic_cardiac_calcinosis | 0.85277712 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.84527437 |
| 115 | MP0004510_myositis | 0.84420589 |
| 116 | MP0005187_abnormal_penis_morphology | 0.84379273 |
| 117 | MP0005310_abnormal_salivary_gland | 0.83891850 |
| 118 | MP0002405_respiratory_system_inflammati | 0.83460288 |
| 119 | MP0002429_abnormal_blood_cell | 0.82511669 |
| 120 | MP0005266_abnormal_metabolism | 0.82254848 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.81292835 |
| 122 | MP0000470_abnormal_stomach_morphology | 0.80880771 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.80523575 |
| 124 | MP0009703_decreased_birth_body | 0.80516299 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.78638496 |
| 126 | MP0003566_abnormal_cell_adhesion | 0.77796071 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.77647781 |
| 128 | MP0005551_abnormal_eye_electrophysiolog | 0.77315254 |
| 129 | MP0003690_abnormal_glial_cell | 0.76919765 |
| 130 | MP0001486_abnormal_startle_reflex | 0.76048929 |
| 131 | MP0001915_intracranial_hemorrhage | 0.75814475 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.75267062 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.75247373 |
| 134 | MP0005389_reproductive_system_phenotype | 0.75077446 |
| 135 | MP0003633_abnormal_nervous_system | 0.74366290 |
| 136 | MP0009763_increased_sensitivity_to | 0.73658882 |
| 137 | MP0003631_nervous_system_phenotype | 0.72553536 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.68467957 |
| 139 | MP0005334_abnormal_fat_pad | 0.68320601 |
| 140 | MP0005275_abnormal_skin_tensile | 0.68278668 |
| 141 | MP0000604_amyloidosis | 0.67978844 |
| 142 | MP0002090_abnormal_vision | 0.67532333 |
| 143 | MP0000598_abnormal_liver_morphology | 0.67332670 |
| 144 | MP0002229_neurodegeneration | 0.65678184 |
| 145 | MP0001501_abnormal_sleep_pattern | 0.64483837 |
| 146 | MP0008775_abnormal_heart_ventricle | 0.63476077 |
| 147 | MP0010386_abnormal_urinary_bladder | 0.62935887 |
| 148 | MP0002067_abnormal_sensory_capabilities | 0.62742090 |
| 149 | MP0005164_abnormal_response_to | 0.61394184 |
| 150 | MP0008004_abnormal_stomach_pH | 0.60996967 |
| 151 | MP0002160_abnormal_reproductive_system | 0.60015395 |
| 152 | MP0000647_abnormal_sebaceous_gland | 0.59606219 |
| 153 | MP0005376_homeostasis/metabolism_phenot | 0.58375137 |
| 154 | MP0002108_abnormal_muscle_morphology | 0.56085345 |
| 155 | MP0005395_other_phenotype | 0.56081691 |
| 156 | MP0001919_abnormal_reproductive_system | 0.55555676 |
| 157 | MP0002876_abnormal_thyroid_physiology | 0.54360959 |
| 158 | MP0004036_abnormal_muscle_relaxation | 0.53749877 |
| 159 | MP0001958_emphysema | 0.53329973 |
| 160 | MP0000778_abnormal_nervous_system | 0.52818583 |
| 161 | MP0006276_abnormal_autonomic_nervous | 0.52771384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 4.87697519 |
| 2 | Genetic anticipation (HP:0003743) | 4.12648895 |
| 3 | Fair hair (HP:0002286) | 3.78693104 |
| 4 | Hyperventilation (HP:0002883) | 3.75534305 |
| 5 | Pancreatic cysts (HP:0001737) | 3.51809371 |
| 6 | Volvulus (HP:0002580) | 3.32570500 |
| 7 | Absent frontal sinuses (HP:0002688) | 3.24987992 |
| 8 | Gaze-evoked nystagmus (HP:0000640) | 3.20619843 |
| 9 | Macroorchidism (HP:0000053) | 3.18717562 |
| 10 | Pancreatic fibrosis (HP:0100732) | 3.15401046 |
| 11 | Protruding tongue (HP:0010808) | 3.14367155 |
| 12 | Abnormality of the renal medulla (HP:0100957) | 3.11559222 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.07204443 |
| 14 | Abnormality of the renal cortex (HP:0011035) | 3.05812340 |
| 15 | Hematochezia (HP:0002573) | 3.04916335 |
| 16 | Nephronophthisis (HP:0000090) | 2.95892023 |
| 17 | Colitis (HP:0002583) | 2.89756221 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 2.88851658 |
| 19 | Chronic hepatic failure (HP:0100626) | 2.88777590 |
| 20 | Periodontitis (HP:0000704) | 2.71883191 |
| 21 | True hermaphroditism (HP:0010459) | 2.69862890 |
| 22 | Stomatitis (HP:0010280) | 2.69748558 |
| 23 | Tubulointerstitial nephritis (HP:0001970) | 2.59036121 |
| 24 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.54668218 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 2.53235046 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 2.53235046 |
| 27 | Heterotopia (HP:0002282) | 2.51671496 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.50730333 |
| 29 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.45205128 |
| 30 | Long eyelashes (HP:0000527) | 2.42587161 |
| 31 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.41919632 |
| 32 | Acanthocytosis (HP:0001927) | 2.41408195 |
| 33 | Recurrent viral infections (HP:0004429) | 2.40588856 |
| 34 | Hypoplasia of the thymus (HP:0000778) | 2.39033142 |
| 35 | Poor coordination (HP:0002370) | 2.37494806 |
| 36 | Absent speech (HP:0001344) | 2.35820930 |
| 37 | Urethral obstruction (HP:0000796) | 2.34860374 |
| 38 | * Narrow palate (HP:0000189) | 2.33023496 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.30862693 |
| 40 | Thyroid carcinoma (HP:0002890) | 2.30571198 |
| 41 | Abnormal hair whorl (HP:0010721) | 2.30009123 |
| 42 | Stomach cancer (HP:0012126) | 2.29457276 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.28882302 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28708162 |
| 45 | Febrile seizures (HP:0002373) | 2.28650477 |
| 46 | Cystic liver disease (HP:0006706) | 2.25212358 |
| 47 | Chronic diarrhea (HP:0002028) | 2.24837095 |
| 48 | Gingival bleeding (HP:0000225) | 2.24612489 |
| 49 | Prominent nose (HP:0000448) | 2.22817209 |
| 50 | Myocardial infarction (HP:0001658) | 2.20171945 |
| 51 | Congenital stationary night blindness (HP:0007642) | 2.17794737 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.17602676 |
| 53 | Abnormality of the ischium (HP:0003174) | 2.16212588 |
| 54 | Hip dysplasia (HP:0001385) | 2.15941510 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.15797846 |
| 56 | Tented upper lip vermilion (HP:0010804) | 2.15365768 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.13922032 |
| 58 | Tubular atrophy (HP:0000092) | 2.13053563 |
| 59 | Hypoplastic iliac wings (HP:0002866) | 2.12878955 |
| 60 | Mitral stenosis (HP:0001718) | 2.12679278 |
| 61 | T lymphocytopenia (HP:0005403) | 2.11945123 |
| 62 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.11864762 |
| 63 | Acute myeloid leukemia (HP:0004808) | 2.11731307 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.10624736 |
| 65 | Aortic aneurysm (HP:0004942) | 2.09931686 |
| 66 | Cerebral aneurysm (HP:0004944) | 2.06178155 |
| 67 | Spondylolisthesis (HP:0003302) | 2.05747123 |
| 68 | Gingivitis (HP:0000230) | 2.03783922 |
| 69 | Hypoplastic ischia (HP:0003175) | 2.02318696 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 1.99994229 |
| 71 | Renal cortical cysts (HP:0000803) | 1.99686258 |
| 72 | Lip pit (HP:0100267) | 1.96708614 |
| 73 | Attenuation of retinal blood vessels (HP:0007843) | 1.96523541 |
| 74 | Drooling (HP:0002307) | 1.93477842 |
| 75 | Thyroiditis (HP:0100646) | 1.93245529 |
| 76 | Clumsiness (HP:0002312) | 1.92973218 |
| 77 | Abnormality of secondary sexual hair (HP:0009888) | 1.92167902 |
| 78 | Abnormality of the axillary hair (HP:0100134) | 1.92167902 |
| 79 | Abnormality of T cell number (HP:0011839) | 1.91357345 |
| 80 | Abnormality of the nasal septum (HP:0000419) | 1.91250904 |
| 81 | Congenital primary aphakia (HP:0007707) | 1.90116467 |
| 82 | Overgrowth (HP:0001548) | 1.88417099 |
| 83 | Short chin (HP:0000331) | 1.88321608 |
| 84 | Obsessive-compulsive behavior (HP:0000722) | 1.88157482 |
| 85 | Gait imbalance (HP:0002141) | 1.87958876 |
| 86 | Increased CSF protein (HP:0002922) | 1.85851310 |
| 87 | IgM deficiency (HP:0002850) | 1.84887523 |
| 88 | Neoplasm of the adrenal cortex (HP:0100641) | 1.84389741 |
| 89 | Neonatal hypoglycemia (HP:0001998) | 1.84234853 |
| 90 | Widely spaced teeth (HP:0000687) | 1.84076116 |
| 91 | Congenital hepatic fibrosis (HP:0002612) | 1.83981775 |
| 92 | Abnormality of the labia majora (HP:0012881) | 1.81875882 |
| 93 | Postaxial foot polydactyly (HP:0001830) | 1.81792075 |
| 94 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.81330553 |
| 95 | Recurrent skin infections (HP:0001581) | 1.80353194 |
| 96 | Joint hemorrhage (HP:0005261) | 1.79872952 |
| 97 | Excessive salivation (HP:0003781) | 1.79801504 |
| 98 | Generalized hypopigmentation of hair (HP:0011358) | 1.79631176 |
| 99 | Hyperkalemia (HP:0002153) | 1.79384075 |
| 100 | Arterial thrombosis (HP:0004420) | 1.78391322 |
| 101 | * Truncal obesity (HP:0001956) | 1.78243597 |
| 102 | Anhidrosis (HP:0000970) | 1.77874215 |
| 103 | Subacute progressive viral hepatitis (HP:0006572) | 1.77809110 |
| 104 | Broad-based gait (HP:0002136) | 1.77777630 |
| 105 | Highly arched eyebrow (HP:0002553) | 1.76189855 |
| 106 | Progressive hearing impairment (HP:0001730) | 1.75707028 |
| 107 | Hypoplastic labia majora (HP:0000059) | 1.74987196 |
| 108 | Abnormality of the frontal sinuses (HP:0002687) | 1.74185481 |
| 109 | Short foot (HP:0001773) | 1.72680509 |
| 110 | Cellulitis (HP:0100658) | 1.72578030 |
| 111 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.72234960 |
| 112 | IgA deficiency (HP:0002720) | 1.71868373 |
| 113 | Depressed nasal tip (HP:0000437) | 1.71528120 |
| 114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.71480942 |
| 115 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.71118787 |
| 116 | Genital tract atresia (HP:0001827) | 1.70470268 |
| 117 | Nephrogenic diabetes insipidus (HP:0009806) | 1.69754204 |
| 118 | Tubulointerstitial abnormality (HP:0001969) | 1.69241214 |
| 119 | Submucous cleft hard palate (HP:0000176) | 1.69099981 |
| 120 | Papillary thyroid carcinoma (HP:0002895) | 1.68975502 |
| 121 | Impaired smooth pursuit (HP:0007772) | 1.68555628 |
| 122 | Dysmetric saccades (HP:0000641) | 1.67823196 |
| 123 | Progressive inability to walk (HP:0002505) | 1.67595116 |
| 124 | Absent/shortened dynein arms (HP:0200106) | 1.67356387 |
| 125 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67356387 |
| 126 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.66727825 |
| 127 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.66534637 |
| 128 | Acute lymphatic leukemia (HP:0006721) | 1.66302274 |
| 129 | Curly hair (HP:0002212) | 1.65654491 |
| 130 | Increased number of teeth (HP:0011069) | 1.64919706 |
| 131 | Spinal cord lesions (HP:0100561) | 1.64802158 |
| 132 | Syringomyelia (HP:0003396) | 1.64802158 |
| 133 | Osteomyelitis (HP:0002754) | 1.63456807 |
| 134 | Upper motor neuron abnormality (HP:0002127) | 1.63437732 |
| 135 | Abnormality of the wing of the ilium (HP:0011867) | 1.62585210 |
| 136 | Decreased circulating renin level (HP:0003351) | 1.62219579 |
| 137 | Aqueductal stenosis (HP:0002410) | 1.61945922 |
| 138 | Cystic hygroma (HP:0000476) | 1.61902676 |
| 139 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.61817516 |
| 140 | Recurrent cutaneous fungal infections (HP:0011370) | 1.61817516 |
| 141 | Hypoplastic nipples (HP:0002557) | 1.61128855 |
| 142 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.61111380 |
| 143 | Poikilocytosis (HP:0004447) | 1.60738177 |
| 144 | Cerebellar dysplasia (HP:0007033) | 1.60452327 |
| 145 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.59663755 |
| 146 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.59131154 |
| 147 | Autoimmune hemolytic anemia (HP:0001890) | 1.58967575 |
| 148 | Vaginal atresia (HP:0000148) | 1.58690938 |
| 149 | Abnormality of DNA repair (HP:0003254) | 1.58531856 |
| 150 | Recurrent bronchitis (HP:0002837) | 1.58121970 |
| 151 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.57957845 |
| 152 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.57957845 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.57957845 |
| 154 | * Thick eyebrow (HP:0000574) | 1.57824319 |
| 155 | Abnormality of the common coagulation pathway (HP:0010990) | 1.57594895 |
| 156 | Smooth philtrum (HP:0000319) | 1.57531077 |
| 157 | Ectropion (HP:0000656) | 1.56948400 |
| 158 | Hypoglycemic seizures (HP:0002173) | 1.56363415 |
| 159 | Ocular albinism (HP:0001107) | 1.55747393 |
| 160 | Enlarged penis (HP:0000040) | 1.55236634 |
| 161 | Mediastinal lymphadenopathy (HP:0100721) | 1.54733449 |
| 162 | Vasculitis (HP:0002633) | 1.53246982 |
| 163 | Aneurysm (HP:0002617) | 1.52270717 |
| 164 | Progressive sensorineural hearing impairment (HP:0000408) | 1.52114778 |
| 165 | Deep philtrum (HP:0002002) | 1.50402418 |
| 166 | Hypoalphalipoproteinemia (HP:0003233) | 1.49733148 |
| 167 | Conjugated hyperbilirubinemia (HP:0002908) | 1.49544233 |
| 168 | Portal hypertension (HP:0001409) | 1.49420028 |
| 169 | Agammaglobulinemia (HP:0004432) | 1.49082691 |
| 170 | Anal stenosis (HP:0002025) | 1.48926666 |
| 171 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.48258117 |
| 172 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.48258117 |
| 173 | Spontaneous hematomas (HP:0007420) | 1.48101024 |
| 174 | Generalized hypopigmentation (HP:0007513) | 1.47710040 |
| 175 | Abnormal platelet volume (HP:0011876) | 1.47309308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.55901037 |
| 2 | CAMK1D | 3.47366511 |
| 3 | CAMK1G | 3.03629849 |
| 4 | AKT3 | 2.94822233 |
| 5 | TAOK3 | 2.88402730 |
| 6 | FRK | 2.63230502 |
| 7 | BRD4 | 2.39201087 |
| 8 | INSRR | 2.38019867 |
| 9 | MAP4K2 | 2.36147785 |
| 10 | JAK1 | 2.26075900 |
| 11 | TYK2 | 2.02177921 |
| 12 | BMPR1B | 2.00035815 |
| 13 | SIK1 | 1.99640128 |
| 14 | ACVR1B | 1.99046620 |
| 15 | MAP4K1 | 1.94129913 |
| 16 | MAP3K10 | 1.93994572 |
| 17 | FGFR3 | 1.91403475 |
| 18 | SGK3 | 1.86058799 |
| 19 | RIPK1 | 1.81201869 |
| 20 | SGK2 | 1.63298675 |
| 21 | RIPK4 | 1.61574388 |
| 22 | NLK | 1.60020805 |
| 23 | MAP3K4 | 1.58027480 |
| 24 | PIK3CG | 1.56789676 |
| 25 | MAP3K13 | 1.51812630 |
| 26 | SIK2 | 1.51455486 |
| 27 | JAK3 | 1.36462927 |
| 28 | MAP3K14 | 1.32839106 |
| 29 | PTK6 | 1.32787072 |
| 30 | CSF1R | 1.32517029 |
| 31 | SCYL2 | 1.29295174 |
| 32 | CDK9 | 1.19572812 |
| 33 | MAPK13 | 1.18282346 |
| 34 | NUAK1 | 1.15103391 |
| 35 | PAK3 | 1.14684912 |
| 36 | PTK2B | 1.13271512 |
| 37 | FGFR2 | 1.11687162 |
| 38 | LATS1 | 1.11601888 |
| 39 | MAP3K7 | 1.11104327 |
| 40 | BLK | 1.11099651 |
| 41 | FGFR4 | 1.10919989 |
| 42 | IKBKE | 1.05349676 |
| 43 | WNK3 | 1.05056644 |
| 44 | EEF2K | 1.04802270 |
| 45 | STK3 | 1.03273294 |
| 46 | STK39 | 1.02991111 |
| 47 | TNIK | 1.00217701 |
| 48 | CDK6 | 0.98850963 |
| 49 | WNK1 | 0.98817717 |
| 50 | MAP3K6 | 0.97667754 |
| 51 | CHUK | 0.97291117 |
| 52 | TTN | 0.97084454 |
| 53 | OXSR1 | 0.96735469 |
| 54 | CASK | 0.96271630 |
| 55 | IRAK1 | 0.94831329 |
| 56 | HCK | 0.94736462 |
| 57 | MTOR | 0.94615194 |
| 58 | JAK2 | 0.94242885 |
| 59 | TGFBR2 | 0.93362059 |
| 60 | KIT | 0.92038958 |
| 61 | PDGFRB | 0.90786726 |
| 62 | ITK | 0.90016877 |
| 63 | PKN2 | 0.89516598 |
| 64 | PRKCH | 0.89229290 |
| 65 | CSK | 0.87889792 |
| 66 | STK38L | 0.87775682 |
| 67 | SGK1 | 0.86341029 |
| 68 | STK4 | 0.85120097 |
| 69 | GRK1 | 0.84087541 |
| 70 | FER | 0.81965918 |
| 71 | STK38 | 0.81519171 |
| 72 | NEK6 | 0.80254788 |
| 73 | ADRBK2 | 0.80062751 |
| 74 | STK10 | 0.79744995 |
| 75 | HIPK2 | 0.79341313 |
| 76 | PRKAA2 | 0.78203988 |
| 77 | NTRK3 | 0.77417597 |
| 78 | PDK1 | 0.75926530 |
| 79 | ATR | 0.73866508 |
| 80 | NEK2 | 0.72809542 |
| 81 | BTK | 0.72059730 |
| 82 | PRKAA1 | 0.72021848 |
| 83 | SYK | 0.71501357 |
| 84 | ADRBK1 | 0.70166386 |
| 85 | MARK3 | 0.69785137 |
| 86 | MAP2K4 | 0.69418548 |
| 87 | SGK223 | 0.69153574 |
| 88 | SGK494 | 0.69153574 |
| 89 | ERBB3 | 0.68731188 |
| 90 | TXK | 0.67964355 |
| 91 | LCK | 0.67958779 |
| 92 | EPHA3 | 0.67105646 |
| 93 | TEC | 0.66547193 |
| 94 | ERBB2 | 0.65877205 |
| 95 | MAP3K2 | 0.65623497 |
| 96 | ERN1 | 0.65190949 |
| 97 | EGFR | 0.64858407 |
| 98 | RET | 0.64387673 |
| 99 | SIK3 | 0.64127685 |
| 100 | NEK9 | 0.64029286 |
| 101 | PRKCQ | 0.61627451 |
| 102 | TNK2 | 0.61581542 |
| 103 | FES | 0.61498714 |
| 104 | RPS6KB1 | 0.60710797 |
| 105 | ATM | 0.59953709 |
| 106 | STK11 | 0.59317428 |
| 107 | DAPK2 | 0.59063063 |
| 108 | TRIB3 | 0.58798435 |
| 109 | ZAP70 | 0.57869919 |
| 110 | MELK | 0.57612987 |
| 111 | ZAK | 0.57348221 |
| 112 | BRSK2 | 0.57288173 |
| 113 | YES1 | 0.56232312 |
| 114 | PIM1 | 0.55849451 |
| 115 | PLK2 | 0.54182014 |
| 116 | MST1R | 0.52396298 |
| 117 | TRPM7 | 0.51633787 |
| 118 | IRAK3 | 0.50940940 |
| 119 | CAMK4 | 0.50541095 |
| 120 | BMPR2 | 0.50530012 |
| 121 | FLT3 | 0.49428902 |
| 122 | MARK2 | 0.49128948 |
| 123 | IKBKB | 0.48846806 |
| 124 | GRK6 | 0.48829477 |
| 125 | OBSCN | 0.48500052 |
| 126 | CDC7 | 0.47722706 |
| 127 | MAPK10 | 0.47676334 |
| 128 | MKNK2 | 0.47565473 |
| 129 | MAPK7 | 0.47019057 |
| 130 | CAMK1 | 0.46484456 |
| 131 | CAMKK1 | 0.46354794 |
| 132 | DYRK1A | 0.44835504 |
| 133 | CAMKK2 | 0.44357382 |
| 134 | MAP2K6 | 0.43659733 |
| 135 | PDPK1 | 0.43384096 |
| 136 | TGFBR1 | 0.42928925 |
| 137 | PRKCE | 0.42290253 |
| 138 | PIK3CA | 0.42275695 |
| 139 | CDC42BPA | 0.42214491 |
| 140 | PNCK | 0.40830645 |
| 141 | WNK4 | 0.37624051 |
| 142 | BCR | 0.37458187 |
| 143 | CSNK1D | 0.36126999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysine degradation_Homo sapiens_hsa00310 | 2.29279229 |
| 2 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.04818403 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.98609192 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82436308 |
| 5 | ABC transporters_Homo sapiens_hsa02010 | 1.78610496 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.71892799 |
| 7 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.69820615 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.65589997 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50870311 |
| 10 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.45086035 |
| 11 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.41193762 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30565201 |
| 13 | Insulin resistance_Homo sapiens_hsa04931 | 1.30102058 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27952193 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22521596 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21310222 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.21075935 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18864746 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15867334 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13546546 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.12497916 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10660901 |
| 23 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06551642 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04635260 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04373329 |
| 26 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.02913240 |
| 27 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02359786 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.02225453 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01999448 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98144531 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97771978 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97143186 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94214159 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94002327 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93751616 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 0.93538396 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93037636 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92982171 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92318611 |
| 40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91921369 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91381380 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90839768 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90663789 |
| 44 | Nicotine addiction_Homo sapiens_hsa05033 | 0.90000987 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 0.89893835 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89862248 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89728744 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89078467 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88833389 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88626357 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.88270003 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87787143 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.85986814 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85701234 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85204770 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84888836 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84376841 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.84263556 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84086278 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83118587 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.82876228 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82425034 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82264213 |
| 64 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81796375 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81771385 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80741164 |
| 67 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80482560 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80280089 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79998423 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79800444 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79746944 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78720324 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78684869 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78354938 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78097386 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77335567 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76574788 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.76205691 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75607931 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74529250 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74450143 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.74346703 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.74140798 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73788517 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72990303 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72500325 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72408403 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71747274 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.70441595 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68463349 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67712744 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67092744 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66731294 |
| 94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66675798 |
| 95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66196104 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65389256 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65212340 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65117940 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65116255 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64888531 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64864562 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64845470 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64679170 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64518301 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63952040 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63144725 |
| 107 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62572384 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61392696 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60855267 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.60522450 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59950582 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59928745 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59465231 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.59389504 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59343503 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59280718 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58833938 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57660193 |
| 119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57578951 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57384752 |
| 121 | Melanoma_Homo sapiens_hsa05218 | 0.56868267 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56586349 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.56456181 |
| 124 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56386737 |
| 125 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55535395 |
| 126 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55204685 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55146312 |
| 128 | Adherens junction_Homo sapiens_hsa04520 | 0.55022102 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54826569 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54804889 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54618927 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.54294069 |
| 133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54107180 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53363948 |
| 135 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52197716 |
| 136 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51966154 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51532205 |
| 138 | Morphine addiction_Homo sapiens_hsa05032 | 0.51451826 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50131716 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49970587 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49739656 |

